These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 20014960)
1. Pathogenic mechanisms in systemic lupus erythematosus. Perl A Autoimmunity; 2010 Feb; 43(1):1-6. PubMed ID: 20014960 [TBL] [Abstract][Full Text] [Related]
2. Emerging new pathways of pathogenesis and targets for treatment in systemic lupus erythematosus and Sjogren's syndrome. Perl A Curr Opin Rheumatol; 2009 Sep; 21(5):443-7. PubMed ID: 19584730 [TBL] [Abstract][Full Text] [Related]
3. T-cell and B-cell signaling biomarkers and treatment targets in lupus. Perl A; Fernandez DR; Telarico T; Doherty E; Francis L; Phillips PE Curr Opin Rheumatol; 2009 Sep; 21(5):454-64. PubMed ID: 19550330 [TBL] [Abstract][Full Text] [Related]
4. The role of nitric oxide in abnormal T cell signal transduction in systemic lupus erythematosus. Nagy G; Perl A Clin Immunol; 2006; 118(2-3):145-51. PubMed ID: 16406340 [TBL] [Abstract][Full Text] [Related]
5. T- and B-cell abnormalities in systemic lupus erythematosus. Nagy G; Koncz A; Perl A Crit Rev Immunol; 2005; 25(2):123-40. PubMed ID: 15952933 [TBL] [Abstract][Full Text] [Related]
6. Neutrophil Extracellular Trap Mitochondrial DNA and Its Autoantibody in Systemic Lupus Erythematosus and a Proof-of-Concept Trial of Metformin. Wang H; Li T; Chen S; Gu Y; Ye S Arthritis Rheumatol; 2015 Dec; 67(12):3190-200. PubMed ID: 26245802 [TBL] [Abstract][Full Text] [Related]
7. Systems biology of lupus: mapping the impact of genomic and environmental factors on gene expression signatures, cellular signaling, metabolic pathways, hormonal and cytokine imbalance, and selecting targets for treatment. Perl A Autoimmunity; 2010 Feb; 43(1):32-47. PubMed ID: 20001421 [TBL] [Abstract][Full Text] [Related]
8. Activation of mammalian target of rapamycin controls the loss of TCRzeta in lupus T cells through HRES-1/Rab4-regulated lysosomal degradation. Fernandez DR; Telarico T; Bonilla E; Li Q; Banerjee S; Middleton FA; Phillips PE; Crow MK; Oess S; Muller-Esterl W; Perl A J Immunol; 2009 Feb; 182(4):2063-73. PubMed ID: 19201859 [TBL] [Abstract][Full Text] [Related]
11. [Immunometabolism and systemic lupus erythematosus]. Xiao YB; Guo MY; Zuo XX Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Dec; 50(6):1120-1124. PubMed ID: 30562794 [TBL] [Abstract][Full Text] [Related]
12. Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation. Chauhan SK; Singh VV; Rai R; Rai M; Rai G J Clin Immunol; 2013 Jul; 33(5):954-64. PubMed ID: 23564191 [TBL] [Abstract][Full Text] [Related]
13. Annexin A1 as a target for managing murine pristane-induced systemic lupus erythematosus. Mihaylova N; Bradyanova S; Chipinski P; Herbáth M; Chausheva S; Kyurkchiev D; Prechl J; Tchorbanov AI Autoimmunity; 2017 Jun; 50(4):257-268. PubMed ID: 28300427 [TBL] [Abstract][Full Text] [Related]
14. Selective Histone Deacetylase 6 Inhibition Normalizes B Cell Activation and Germinal Center Formation in a Model of Systemic Lupus Erythematosus. Ren J; Catalina MD; Eden K; Liao X; Read KA; Luo X; McMillan RP; Hulver MW; Jarpe M; Bachali P; Grammer AC; Lipsky PE; Reilly CM Front Immunol; 2019; 10():2512. PubMed ID: 31708928 [TBL] [Abstract][Full Text] [Related]
15. Persistent mitochondrial hyperpolarization, increased reactive oxygen intermediate production, and cytoplasmic alkalinization characterize altered IL-10 signaling in patients with systemic lupus erythematosus. Gergely P; Niland B; Gonchoroff N; Pullmann R; Phillips PE; Perl A J Immunol; 2002 Jul; 169(2):1092-101. PubMed ID: 12097418 [TBL] [Abstract][Full Text] [Related]
16. Type I interferon receptor controls B-cell expression of nucleic acid-sensing Toll-like receptors and autoantibody production in a murine model of lupus. Thibault DL; Graham KL; Lee LY; Balboni I; Hertzog PJ; Utz PJ Arthritis Res Ther; 2009; 11(4):R112. PubMed ID: 19624844 [TBL] [Abstract][Full Text] [Related]
17. Assessment of mitochondrial dysfunction in lymphocytes of patients with systemic lupus erythematosus. Perl A; Hanczko R; Doherty E Methods Mol Biol; 2012; 900():61-89. PubMed ID: 22933065 [TBL] [Abstract][Full Text] [Related]
18. Expression of B-cell activating factor of the tumour necrosis factor family (BAFF) in T cells in active systemic lupus erythematosus: the role of BAFF in T cell-dependent B cell pathogenic autoantibody production. Morimoto S; Nakano S; Watanabe T; Tamayama Y; Mitsuo A; Nakiri Y; Suzuki J; Nozawa K; Amano H; Tokano Y; Kobata T; Takasaki Y Rheumatology (Oxford); 2007 Jul; 46(7):1083-6. PubMed ID: 17500077 [TBL] [Abstract][Full Text] [Related]